In lung cancer, AK4 operates as an upstream HIF-1α regulator by stabilizing HIF-1α through the inhibition of its hydroxylation and subsequent degradation [35], whereas in macrophages it acts by enhancing both HIF-1α gene transcription and protein stability [38]. Here, HIF1A is linked to lung carcinoma.